Adiponectin and HMW Oligomers in Relation to Inflammatory Markers in Crohn's Disease Patients.

脂联素和高分子量寡聚体与克罗恩病患者炎症标志物的关系

阅读:7
作者:Marra Maurizio, Mallardo Marta, Nigro Ersilia, Cioffi Iolanda, Leo Camilla, Guarino Alessia Dalila, Castiglione Fabiana, Pasanisi Fabrizio, Daniele Aurora
Background/Objectives: Crohn's disease (CD), a chronic inflammatory gastrointestinal illness, is the result of genetics and environmental factors. Adipose tissue has recently been found to play a significant role in CD. Methods: here, we examined the relationship between adiponectin, HMW oligomers, and CD in 92 patients. Results: first, we verified that the patients' therapies had no influence on the nutritional and biochemical variables. Correlation analysis between HMW adiponectin and nutritional parameters found no relationship; therefore, we investigated its relationship with CD severity and inflammatory markers. Based on adiponectin, we divided patients into tertiles and found that CDAI was lowest in the second and third tertile [I: <19.3 (n = 31); II: 19.3-22.2 (n = 31); III: >22.2 (n = 30)]. Furthermore, IL-6 and CRP were higher in the second and third tertile, while lymphocytes were lower in the second and third tertile. Correlation analysis showed that both adiponectin and HMW oligomers were inversely related to lymphocytes and directly related to CRP. A ROC curve evidenced that patients carrying adiponectin values ≤ 19 performed well in predicting worse CDAI and lymphocyte values (AUCs: 0.826 and 0.806). Next, we divided CD patients into tertiles based on HMW adiponectin, finding that IL-6 was highest in the second and third tertile. Lymphocytes were lowest in the third tertile while CRP values were substantially higher. Conclusions: altogether, these data suggest a biological role for adiponectin and HMW oligomers in CD severity and inflammatory status. However, the molecular effects related to adiponectin in CD remain unclear and further studies are needed to clarify its applicability as a biomarker.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。